医疗机器人公司PROCEPT BioRobotics因折扣披露问题遭证券欺诈诉讼

环球市场播报
Jul 29

  医疗机器人公司PROCEPT BioRobotics正面临证券欺诈集体诉讼。诉讼指控公司在披露一项未公开的折扣计划方面存在问题,导致其股价大幅下跌。

  根据诉讼,PROCEPT BioRobotics在2024年第二季度财报电话会议上,未向投资者充分披露一项给特定客户的“秘密返点”或折扣计划。有分析指出,此类未公开的折扣行为可能被视为不公平的商业行为,因为它并非公开的定价策略,且可能导致收入确认和财务透明度的缺失。

  当市场开始关注这一折扣计划可能对公司利润率、收入确认及整体财务状况产生的负面影响后,公司股价遭受重创。据报道,受此消息影响,PROCEPT BioRobotics股价在单日内下跌了18%。

  在此背景下,投资者权益律师事务所BFA Law已介入调查此案。BFA Law专注于证券欺诈和股东派生诉讼,曾代表投资者处理过多起重大案件。该律所正在调查PROCEPT BioRobotics及其管理层是否在财务披露中进行了虚假陈述或遗漏了重大信息,从而误导了投资者。

  BFA Law鼓励在相关时间段内购买了PROCEPT BioRobotics股票并因此遭受损失的投资者与其联系,以讨论法律权利和可能的追偿方案。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10